CA-VELODYNE/SEOUL-ROBO
Velodyne Lidar, Inc. (Booth #6091), in collaboration with Seoul Robotics , will demonstrate how its smart, powerful lidar solutions advance automation and safety in manufacturing and supply chain solutions at MODEX 2020 in Atlanta, March 9-12. Velodyne will highlight lidar sensors that can be used in robotics, automated guided vehicles (AGV), forklifts and security applications. Velodyne lidar solutions can improve industrial automation, materials handling, yard management and distribution center operations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200227005194/en/
At its MODEX booth, Velodyne will showcase the Puck 32MR™, a lidar sensor which produces a data-rich image with the ability to detect low reflectivity objects at a range of 120 meters. The sensor is optimized for outstanding indoor/outdoor performance, operating in a variety of light conditions. By combining high-resolution 3D perception with a broad vertical field of view, the Puck 32MR accurately detects crosswalks, curbs and obstacles in warehouse aisles for safe and efficient navigation in roadway, commercial and industrial settings.
Velodyne will also highlight the Velarray™, a powerful sensor solution to greatly improve automated safety. Its small, embeddable form factor enables the sensor to be seamlessly integrated into a variety of industrial and robotics equipment. The Velarray produces a robust directional image, day or night.
“As the demands for supply chain efficiency and safety increase and evolve, lidar technology is helping companies vastly improve manufacturing and logistics performance,” said Jon Barad, Vice President of Business Development, Velodyne Lidar. “Supply chain systems need to continue to become smarter and safer, more efficient and further automated. To address these requirements, companies are turning to lidar to play a key role in enabling the next generation of manufacturing and supply chain solutions.”
At Velodyne’s MODEX booth, Seoul Robotics will demonstrate the benefits and applications of Level 5 Control Tower solution, powered by its proprietary AI engine, SENSR™, which is optimized and available commercially to process Velodyne’s rich and reliable 3D data. Seoul Robotics uses artificial intelligence (AI) for detection, counting, classification and tracking of objects in real time. It can accurately track the location, coordinates, speed and direction of objects and predict their path, such as vehicles and people at a distribution center or manufacturing and logistics operation.
“As vehicles and material handling equipment are increasingly automated in logistics yards and distribution centers, industry must develop and deploy in parallel a robust and safe operating environment. This will resolve well-known challenges with trucks and equipment, such as blind spots and occlusion, in order to successfully realize the promised efficiency and economy,” said David Han, Seoul Robotics’ Managing Director of North America & Global Automotive. “Level 5 Control Tower equipped with Velodyne lidar enables exactly that – a robust and cost-effective infrastructure-based perception solution that monitors and guides the movement of automated and conventional vehicles within the entire yard – efficiently and safely.”
About Velodyne Lidar
Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized Velarray™, and the groundbreaking software for driver assistance, Vella™.
About Seoul Robotics
Seoul Robotics is a 3D Perception AI company that specializes in Lidar perception solutions, powered by its proprietary and versatile SENSR™ perception platform suite. Based in Seoul, South Korea with U.S. branch office in Ann Arbor, Michigan, Seoul Robotics is developing customers and projects in the ADAS/AV, Security, Smart Factory and Logistics, and Robotics markets worldwide. Seoul Robotics works collaboratively with partners across the value chain – including Lidar manufacturers, global automotive and industrial OEM’s and Tier 1 & 2 suppliers, engineering companies, and government customers – to advance perception solutions that make robots intelligent. Visit www.seoulrobotics.org for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200227005194/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press release
RoslinCT is performing technology transfer and will support commercial manufacture of Omisirge® for an additional indication following successful clinical trialsOmisirge® now FDA-approved for an expanded patient population in hematologyRoslinCT continues to support and advance multiple cell therapy projects at its Hopkinton, MA facility Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support c
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press release
Leading encryption provider deepens commitment to European financial sector with rigorous new supplier qualification, building on existing UK & Ireland certification. Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It p
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform16.12.2025 02:00:00 CET | Press release
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine-On’s IND submission. The IND was cleared by the U.S. FDA in Q1 2025. Furthermore, Esco Aster is providing technical services for exploratory exosome loading feasibility studies per Shine-On’s instruction. Shine-On Biomedical is an emerging innovator in exosome-based drug delivery. ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G targeted exosome platfo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom